Reporting and/or analysis of contingency strategies and/or treatments resulting from unidentified, unforeseen or unavoidable issues which present during the trial period.

Analysis of the survival rate of the a cohort of patients with clinical and scientific conclusions on the efficacy of CWB for the treatment of EVD during an emergency in poor resource settings. This deliverable refers to the need to employ contingency plans as described in Part B, DOA of this Grant Agreement. The Commission will be informed of all and any changes in the study protocol and will recieve the associated ethical review documents in real time.